|
Match
|
Document |
Document Title |
|
|
US20090297624 |
ARSENIC THERAPY FOR AUTOIMMUNE AND/OR INFLAMMATORY DISEASES IN MICE AND HUMANS
The invention relates to a method for treating and/or preventing autoimmune and/or inflammatory diseases, including the graft-versus-host disease, comprising administering to a patient in need...
|
|
|
US20090246291 |
METHOD AND COMPOSITIONS FOR TREATMENT OF CANCER
The present invention relates to a method of treating cancer in a subject in need thereof, by administering to the subject a combination of sodium meta arsenite and/or arsenic trioxide and a...
|
|
|
US20090162440 |
SODIUM ALGINATE MICROSPHERE VASCULAR EMBOLUS CONTAINING WATER-SOLUBLE DRUG AND PREPARATION AND APPLICATION THEREOF
The present disclosure relates to a kind of sodium alginate microsphere vascular embolus that contains water-soluble drug and preparation and application thereof. The embolus preparation falls into...
|
|
|
US20090130091 |
COMPOUNDS FOR HEDGEHOG PATHWAY BLOCKADE IN PROLIFERATIVE DISORDERS, INCLUDING HEMATOPOIETIC MALIGNANCIES
Elevated Hedgehog (Hh) pathway activity, including ligand stimulated Hh pathway activity, was detected in hematopoietic malignancy cells, and determined to be associated with growth and...
|
|
|
US20090117203 |
KIT FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
To provide a kit for cancer treatment and a pharmaceutical composition for cancer treatment that can inhibit the growth of tumors and cancers in mammals more than ever. The kit for cancer...
|
|
|
US20090098216 |
ARSENIC THERAPY FOR APLS-TYPE AUTOIMMUNE LYMPH-OPROLIFERATIVE SYNDROME IN MICE AND HUMANS
The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
|
|
|
US20090061022 |
Pharmaceutical composition comprising arsenite for the treatment of malignancy
A method for using sodium meta-arsenite (AsO 2 − ) to suppress growing of human cancer cells is provided to find a method of curing human cancers. Effects of sodium-meta arsenite (AsO 2 − ) on...
|
|
|
US20090035389 |
TARGETED PROTEIN CAGES
The present invention provides targeted protein cages for the specific delivery of a variety of agents to cells and tissues and methods of use. The targeted protein cages have exterior targeting...
|
|
|
US20090022831 |
USE OF FRUCTUS SCHISANDRAE AND EXTRACTS THEREOF IN PREVENTING AND DECREASING TOXIC AND SIDE EFFECTS OF ANTINEOPLASTIC DRUGS
Use of Fructus schisandrae in preparation of medicaments for preventing and reducing toxicity and side effects of antineoplastic agents. The toxicity and side effects of antineoplastic agents are...
|
|
|
US20080279961 |
TELOMERE TARGETING AGENTS AS STEM CELLS DIRECTED TREATMENTS
It is demonstrated in the present invention that G-quadruplex ligands can be used to both shorten telomeres and inhibit telomerase by causing telomere uncapping. The invention relates to...
|
|
|
US20080193560 |
Use of arsenic compounds for treatment of pain and inflammation
The present invention relates to the use of arsenic compounds such as sodium meta arsenite (NaAsO 2 ), arsenic trioxide (As 2 O 3 ), and arsenic hexoxide (As 4 O 6 ) or combinations thereof, for...
|
|
|
US20080166425 |
METHOD FOR INHIBITING CANCER USING ARSENIC TRIOXIDE
The invention provides a method for treating cancers that are dependent on cyclin D1 for proliferation, survival, metastasis and differentiation, involving administering a composition containing an...
|
|
|
US20080089951 |
Method for Inhibiting Cancer Using Arsenic Trioxide
It has been discovered that As 2 O 3 suppresses tyrosine kinase receptors, in particular EGFR and IL-6R, by targeting RTKs to lysosomes and/or proteasome for degradation. This is the basis for the...
|
|
|
US20080089950 |
Methods and compositions for modulating the immune system and uses thereof
The present invention provides methods of preventing, treating or ameliorating one or more symptoms of disorders in which modulation of a subject's immune system is beneficial utilizing a lymphoid...
|
|
|
US20080089949 |
Method for treating cancer using oral arsenic trioxide
The invention provides a method for treating cancers that are dependent on cyclin D1 for proliferation, survival, metastasis and differentiation, involving administering effective amount of arsenic...
|
|
|
US20080050384 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds,...
|